Completed PHASE2 INTERVENTIONAL 1-arm NCT00436423

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

Sponsor: Konkuk University Hospital

Conditions Neoplasm Metastasis Pancreatic Neoplasm

Updated 7 times since 2017 Last updated: Oct 31, 2007 Started: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neoplasm Metastasis and Pancreatic Neoplasm, this trial is completed. The trial is conducted by Konkuk University Hospital and has accumulated 7 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Sep 2022 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Konkuk University Hospital
Korea University Anam Hospital
Korea University Ansan Hospital
Korea University Guro Hospital
Seoul Municipal Boramae Hospital
Seoul National University Bundang Hospital
Seoul National University Hospital

Data source: Korea University Anam Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea